Yasuyuki Kawamoto

14PUBLICATIONS
47CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations.

|May 04, 2026
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903).

|Jul 29, 2025
Urinary Titin as a Non-Invasive Biomarker for Sarcopenia Sex Differences in Unresectable Digestive Malignancies: A Retrospective Cohort Study.

Shiho Kaneko, Kazuaki Harada, Masatsugu Ohara

|Apr 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer.

Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey

|Aug 05, 2024
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.

Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto

|Apr 17, 2024
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.

Yasuyuki Kawamoto, Chigusa Morizane, Yoshito Komatsu

Pageof 3

Frequent Collaborators

6 joint publications

Yoshito Komatsu

5 joint publications

Masafumi Ikeda

4 joint publications

Kazuaki Harada

4 joint publications

Satoshi Yuki